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To the Editor, 11 
 12 
I read the paper by Kiberenge and Lam with great interest and would like to comment 13 
on the microbiological presentation of this case study (1).  In the paper the authors describe a 14 
case of fatal hyperammonemia after repeat renal transplantation, but with no etiology 15 
determined.   16 
 17 
 18 
The combination of data presented in the paper as well as information from recent 19 
reports in the literature suggest the hyperammonemia may have been the result of an infection 20 
by the bacteria Ureaplasma spp.. The reasons for this are several fold.  Firstly Ureaplasma 21 
spp. have recently been reported as a pathogen in the context of hyperammonemia among 22 
lung transplant patients.  A study by Bharat et al. identified Ureaplasma within 23 
bronchoalveloar lavage and blood samples from a collection of expired patients who died as a 24 
result of hyperammonemia of unknown etiology (2).  They also identified Ureaplasma as the 25 
sole organism in a number of prospective cases of the same condition.  Finally, Ureaplasma 26 
were absent from all control samples taken from lung transplant patients with no signs of 27 
elevated serum ammonia levels.   28 
 29 
 30 
Although Kiberenge and Lam correctly sent samples for microbiological analysis the 31 
methods used in routine bacterial culture would not have been appropriate to detect the 32 
presence of Ureaplasma due to the fastidious growth requirements of this organism.  33 
Ureaplasma, as the name suggests, utilize urea as their sole energy source resulting in the 34 
production of ammonia and therefore increasing the pH.  In the situation where patients 35 
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present with hyperammonemia, circulating levels of urea will have permitted the replication 36 
of the organism and be responsible for the production of ammonia accounting for the 37 
symptoms.  It should be noted that the authors do state that a urease positive organism may 38 
have been present accounting for the symptoms, but was not culturable due to the 39 
administration of broad spectrum antibiotics. 40 
 41 
 42 
With respect the use of broad spectrum antibiotics these were not defined within the 43 
paper.  If the antibiotics belonged the beta-lactam family these will have had no effect upon 44 
Ureaplasma as, unlike many bacteria, these organisms do not have a cell wall which is the 45 
primary site of action for these drugs.  Similarly aminoglycosides have been shown to have 46 
universally poor activity against Ureaplasma.  In general only three classes of antibiotic have 47 
activity against these organisms.  These include the macrolides, tetracyclines and 48 
fluoroquinolones, although resistance to all three classes have been reported (3). 49 
 50 
 51 
In the cases of hyperammonemia among lung transplant patients Bahrat et al., 52 
demonstrated that upon administration of the anti-ureaplasma antibiotics levofloxacin and 53 
azithromycin the patients rapidly cleared the infection as well as correlating with the 54 
resolution of symptoms.  In one case the treatment with azithromycin did not clear the 55 
organism or resolve the symptoms, but this was attributed to the identification of a macrolide 56 
resistant strain (azithromycin minimum inhibitory concentration of 256 µg/ml).  Therefore if 57 
non-effective antibiotics were administered in the case presented by Kiberenge and Lam this 58 
would have accounted for the persistent symptoms. 59 
 60 
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 61 
Although Ureaplasma spp. can be found in the urogenital tract of 40 – 80 % of 62 
healthy females they have been implicated in a number of complications associated with 63 
kidney transplantation (4-8).  A study by Ekiel et al., identified that Ureaplasma were more 64 
prevalent in the samples from kidney transplant patients (40 %) compared with controls (27.5 65 
%), and Ureaplasma urealyticum was more prevalent in the study group (10 %) versus 66 
Ureaplasma parvum (2.5%) (9).  It is not known if these infections were the result of 67 
endogenous Ureaplasma within the patient gaining a foot hold as a result of 68 
immunosuppressive treatment or whether they are transmitted to the recipient patient from 69 
either the donor organ or blood products. 70 
 71 
 72 
In light of these findings clinicians and microbiologists alike should be mindful of 73 
identification techniques for these organisms in particular when hyperammonemia patients 74 
have culture negative results.  The use specific selective media or molecular techniques, such 75 
as 16s rRNA or Ureaplasma specific PCR, should be utilised to aid in the identification of 76 
these fastidious organisms and permit the administration of appropriate antimicrobial therapy 77 
to aid clearance of infection and resolution of symptoms. 78 
 79 
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